Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes and perceptions amongst resident doctors

Journal of Pharmaceutical Sciences and Research

Volumn 3, Issue 2, 2011, Pages 1064-1069

  Gupta, Pankaj ^a   Udupa, Aaditya ^b  

^a KEM HOSPITAL   (India)

^b B J MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; INDIA; KNOWLEDGE; MALE; MOTIVATION; PERCEPTION; PHYSICIAN ATTITUDE; QUESTIONNAIRE; RESIDENT; RESPONSIBILITY;

EID: 79952410427     PISSN: None     EISSN: 09751459     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients-a meta-analysis of prospective studies. JAMA 1998; 279: 1200-5. Doi:10.1001/jama.279.15.1200. Available from: http://jama.amaassn.org/cgi/content/full/279/15/1200.
2. Classen DC, Pestotnik SL, Evans RS et al. Adverse drug events in hospitalized patients. JAMA 1997;277(4):301-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9002492.
3. World Health Organization. Safety of medicines: A guide to detecting and reporting adverse drug reactions. Geneva: 2002. WHO/EDM/QSM/2002.2
4. Edwards I, Olsson S. WHO: global monitoring. In Pharmacovigilance Edited by: Mann RD, Andrew E. Chichester: John Wiley & Sons; 2002:169-182. Available from: http://onlinelibrary.wiley.com/doi/10.1002/0470853093.ch13/summary
5. Ahmad SR. Adverse drug event monitoring at the Food and Drug Administration. J Gen Intern Med 2003, 285:437-443. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1494803/
6. Wysowsky DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch Intern Med 2005, 165:1363-1369. Available from: http://archinte.amaassn.org/cgi/content/full/165/12/1363.
7. Lexchin J. Is there a role for spontaneous reporting of adverse drug reactions? CMAJ 2006, 174:191-192. Available from: http://www.cmaj.ca/cgi/reprint/174/2/191.
8. Feely J, Moriarty S, O'Connor P: Stimulating reporting of adverse drug reaction by using a fee. Br Med J 1990, 300:22-23. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661889/pdf/bmj00160-0028.pdf
9. Inman WH: Attitudes to adverse drug-reaction reporting. Br J Clin Pharmacol 1996, 41:433-435. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8735689
10. Lopez-Gonzalez E, Herdeiro MT, Figueiras A: Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009, 32:19-31. Available from: http://jama.amaassn.org/cgi/content/full/279/15/1200.
11. Qing, L., Su-min, Z., Hua-ting, C., Shi-ping, F., Xin, Y., Dong, L., Lu-yuan, S., Fan-dian, Z., 2004: Awareness and attitudes of healthcare professional in Wuhan, China to the reporting of adverse drug reactions. Chinese Medical Journal,117(6): 856-861. Available at: http://www.cmj.org/periodical/PaperList.asp?id=LW7205.
12. Belton, KJ., Lewis, SC., Payne, S., Rawlins, M.D., and Wood S.M., 1995. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol, 39(3): 223-226. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1364995/.
13. Bateman, D.N., Sanders, G.L.S., Rawlins, M.D., 1992. Attitudes to adverse drug reaction reporting in the Northern Region. Br. J. Clin. Pharmacol., 34(5): 421-426. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1381471/?tool=pubmed.
14. Tabali, M., Jeschke, E., Bockelbrink, A., Witt, C.M., Willich, S.N., Ostermann, T., Matthes, H., 2009. Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine. BMC Public Health, 9:274. Available at: http://www.biomedcentral.com/1471-2458/9/274. Doi:10.1186/1471-2458-9-274